Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR*D: Sequenced Treatment Alternatives to Relieve Depression
NCT00021528Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of citalopram in major depressive disorder (MDD) (7 arms), sponsored by National Institute of Mental Health. Primary endpoint: Remission of Depressive Symptoms (HAM-D) at 14 weeks. Started Jul 2001; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00021528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021528.